- Home
- CFFI vs LRMR Comparison
CFFI vs LRMR Comparison
Compare CFFI & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- LRMR
- Stock Information
- Founded
- CFFI 1927
- LRMR N/A
- Country
- CFFI United States
- LRMR United States
- Employees
- CFFI N/A
- LRMR N/A
- Industry
- CFFI Major Banks
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- CFFI Finance
- LRMR Health Care
- Exchange
- CFFI Nasdaq
- LRMR Nasdaq
- Market Cap
- CFFI 211.9M
- LRMR 204.9M
- IPO Year
- CFFI 1998
- LRMR N/A
- Fundamental
- Price
- CFFI $66.83
- LRMR $3.88
- Analyst Decision
- CFFI
- LRMR Strong Buy
- Analyst Count
- CFFI 0
- LRMR 7
- Target Price
- CFFI N/A
- LRMR $17.86
- AVG Volume (30 Days)
- CFFI 39.2K
- LRMR 892.3K
- Earning Date
- CFFI 07-24-2025
- LRMR 08-06-2025
- Dividend Yield
- CFFI 2.75%
- LRMR N/A
- EPS Growth
- CFFI 32.37
- LRMR N/A
- EPS
- CFFI 7.57
- LRMR N/A
- Revenue
- CFFI $122,075,000.00
- LRMR N/A
- Revenue This Year
- CFFI N/A
- LRMR N/A
- Revenue Next Year
- CFFI N/A
- LRMR N/A
- P/E Ratio
- CFFI $8.83
- LRMR N/A
- Revenue Growth
- CFFI 7.42
- LRMR N/A
- 52 Week Low
- CFFI $50.70
- LRMR $1.61
- 52 Week High
- CFFI $89.90
- LRMR $9.88
- Technical
- Relative Strength Index (RSI)
- CFFI 54.39
- LRMR 69.65
- Support Level
- CFFI $62.47
- LRMR $3.11
- Resistance Level
- CFFI $69.66
- LRMR $4.01
- Average True Range (ATR)
- CFFI 1.47
- LRMR 0.27
- MACD
- CFFI 0.29
- LRMR 0.03
- Stochastic Oscillator
- CFFI 60.64
- LRMR 85.64
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.